Remus Pharmaceuticals IPO subscription status started on Wednesday May 17, 2023 and will close on May 19, 2023. Remus Pharmaceuticals IPO to raise around ₹47.69 crores via IPO. The retail quota is 35%, QIB is 50%, and NII is 10%. The price band is fixed at ₹1150 to ₹1229 per equity share.
The post Remus Pharmaceuticals IPO Subscription Status – IPO Open appeared first on IPO Watch – Latest IPO News, Upcoming IPO, Recent IPO 2022.